Inventor · disambiguated record
Robert Zeiser
Also filed as: ZEISER ROBERT
3 granted patents·3 pending applications·1 citations·filing 2016–2023
52Inventor score
Files withMALLINCKRODT PHARMACEUTICALS IRELAND LTD2UNIV MINNESOTA2NOVARTIS AG1THERAKOS DEVELOPMENT LTD1
Top patents by PatentIndex Score
6 records- 0172US10894061B2Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cellsUNIV MINNESOTA·Filed 2016·Granted Jan 19, 2021·1 cites·30 claims
- 0265US12234480B2Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cellsUNIV MINNESOTA·Filed 2020·Granted Feb 25, 2025·0 cites·8 claims
- 0355US2024307497A1Adiponectin alone or in combination with extracorporeal photopheresis (ecp) for immune related adverse events of immune checkpoint inhibitorsMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2023·Application pending·0 cites
- 0454US12491248B2Method for generating immunoregulatory cells in a blood-derived sampleTHERAKOS DEVELOPMENT LTD·Filed 2020·Granted Dec 9, 2025·0 cites·20 claims
- 0552US2023165961A1Method of extracorporeal photopheresis for immune-related adverse eventsMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2023·Application pending·0 cites
- 0648US2023338374A1Mdm2 inhibitors for use in the treatment or prevention of hematologic neoplasm relapse after hematopoietic cell transplantationNOVARTIS AG·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Zeiser files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →